AbbVie | ABBV - EPS Earnings Per Share


AbbVie reported $2.65 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 3.84 1.86 Oct/23
FY2026Q2 Jun/2026 3.76 2.97 Jul/31
FY2026Q1 Mar/2026 2.65 3.01 2.46 Apr/29
FY2025Q4 Dec/2025 2.71 3.35 2.16 Feb/04
FY2025Q3 Sep/2025 1.86 3.26 3.00 Oct/31




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Abbott USD 1.31 0.16 Jun/2026
ALKERMES USD 0 0.4 Jun/2026
Amgen USD 5.15 0.14 Mar/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Eisai JPY -11.53 72.47 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
J&J USD 2.9 0.2 Jun/2026
Medtronic USD 1.55 0.19 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Pacira USD 0.6 0.54 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 1.88 0.35 Mar/2026
UCB EUR 5.65 3.21 Dec/2025
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026
Zoetis USD 1.53 0.05 Mar/2026